Jevtana® (cabazitaxel)
for Prostate Cancer

Jevtana (cabazitaxel) is an antineoplastic cancer medicine used to treat metastatic prostate cancer that no longer responds to treatments lowering testosterone. It works by interfering with the growth and spread of cancer cells, slowing or stopping their growth. Jevtana is given alongside prednisone, typically when prostate cancer worsens after previous treatments, including docetaxel.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Prostate Cancer